Gillis Jonathan reported grant involving 6,020 shares of MapLight Therapeutics, Inc. at $0.00 for $0 on Aug 17, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
CAO and Interim CFO
CAO and Interim CFO
Filed Aug 19, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
6,020Voting Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
150,260Direct
Trade date
Aug 17, 2026Grant
Filed
Aug 19, 2026, 6:35 PM ET2-day reporting delay
Accession
0001709954-26-000012Code A · Transaction 12075
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 17, 2026Grant2,813$0.00$0Trade 12078
Aug 17, 2026Grant24,455$0.00$0Trade 12077
Aug 17, 2026Grant2,222$0.00$0Trade 12076
4 transaction rows in this filing. Joint filers share the same rows.

MPLT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MPLT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +212%1w ago +0.2%1d ago −3.3%
Returns since7d +5.8%30d −10%90d180d1y

Footnotes in full

F1: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date. F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. F3: Represents an RSU award. The RSUs shall vest in 8 equal quarterly installments commencing on October 1, 2026, subject to the Reporting Person's continued service through each vesting date. F4: 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date. F5: The option share vest in 24 equal monthly installments commencing on August 1, 2026, subject to the Reporting Person's continued service through each vesting date.